litlas
Log inCreate account

Manfred Kaufmann

Active 1979–2019

63
Papers
20,159
Citations
62
h-index
63
i10-index

Citations

Citations per year for Manfred Kaufmann1974: 1 citations1980: 1 citations1984: 1 citations1985: 4 citations1986: 1 citations1987: 1 citations1988: 2 citations1989: 4 citations1990: 4 citations1991: 3 citations1992: 1 citations1993: 1 citations1995: 3 citations1996: 8 citations1997: 6 citations1998: 7 citations1999: 21 citations2000: 25 citations2001: 38 citations2002: 46 citations2003: 64 citations2004: 90 citations2005: 110 citations2006: 99 citations2007: 160 citations2008: 174 citations2009: 159 citations2010: 197 citations2011: 213 citations2012: 199 citations2013: 251 citations2014: 219 citations2015: 199 citations2016: 175 citations2017: 176 citations2018: 157 citations2019: 450 citations2020: 500 citations2021: 400 citations2022: 293 citations2023: 166 citations2024: 261 citations2025: 115 citations2026: 3 citations1975–1979: no citations, so these years are not shown1981–1983: no citations, so these years are not shown1994: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,729 citing papers, 24.1% of this breakdownGermany: 601 citing papers, 8.4% of this breakdownChina: 550 citing papers, 7.7% of this breakdownUnited Kingdom: 497 citing papers, 6.9% of this breakdownItaly: 384 citing papers, 5.4% of this breakdownFrance: 317 citing papers, 4.4% of this breakdownCanada: 280 citing papers, 3.9% of this breakdownSwitzerland: 238 citing papers, 3.3% of this breakdownBelgium: 216 citing papers, 3% of this breakdownNetherlands: 197 citing papers, 2.8% of this breakdownSpain: 195 citing papers, 2.7% of this breakdownAustralia: 183 citing papers, 2.6% of this breakdown
0%24.1%Other 24.8%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology47.1%
  • Medicine46.4%
  • Immunology and Microbiology2.2%
  • Computer Science0.8%
  • Materials Science0.7%
  • Engineering0.7%
  • Other2.1%

Topics

  • Breast Cancer Treatment Studies11.9%
  • HER2/EGFR in Cancer Research6.7%
  • Breast Lesions and Carcinomas4%
  • Cancer Cells and Metastasis3.2%
  • Advanced Breast Cancer Therapies3.1%
  • Cancer Treatment and Pharmacology2.7%
  • Other68.4%

Coauthors

All papers

Open in search
  1. Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes

    Authors: Gϋnter von Minckwitz, Michael Untch, Jens‐Uwe Blohmer, Serban Dan Costa, Holger Eidtmann, Peter A. Fasching, Bernd Gerber, W. Eiermann, J. Hilfrich, Jens Huober, Christian Jackisch, Manfred Kaufmann, Gottfried E. Konecny, Carsten Denkert, Valentina Nekljudova, Keyur Mehta, Sibylle Loibl - Journal of Clinical Oncology 2012 cited by 2,674

  2. A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors

    Authors: Martin Filipits, Margaretha Rudas, R. Jakesz, Peter Dubsky, Florian Fitzal, Christian F. Singer, Otto Dietze, Richard Greil, Andrea Jelen, P. Sevelda, Christa Freibauer, Volkmar Müller, F. Jänicke, Marcus Schmidt, H. Kölbl, Achim Rody, Manfred Kaufmann, Werner Schroth, Hiltrud Brauch, Matthias Schwab, Péter Fritz, Karsten E. Weber, Inke Sabine Feder, Guido Hennig, Ralf Kronenwett, Mathias Gehrmann, Michael Gnant - Clinical Cancer Research 2011 cited by 728

  3. Response-Guided Neoadjuvant Chemotherapy for Breast Cancer

    Authors: Gϋnter von Minckwitz, Jens‐Uwe Blohmer, Serban Dan Costa, Carsten Denkert, Holger Eidtmann, W. Eiermann, Bernd Gerber, Claus Hanusch, J. Hilfrich, Jens Huober, Christian Jackisch, Manfred Kaufmann, Sherko Kümmel, Stefan Paepke, Andreas Schneeweiß, Michael Untch, Dirk M. Zahm, Keyur Mehta, Sibylle Loibl - Journal of Clinical Oncology 2013 cited by 425

  4. Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen

    Authors: Mitch Dowsett, Jack Cuzick, J. N. Ingle, Alan S. Coates, John Forbes, Judith M. Bliss, Marc Buyse, Michael Baum, Aman U. Buzdar, Marco Colleoni, R. Charles Coombes, Claire Snowdon, Michael Gnant, R. Jakesz, Manfred Kaufmann, Francesco Boccardo, Jon Godwin, Christina Davies, Richárd Pető - Journal of Clinical Oncology 2009 cited by 815

  5. Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial

    Authors: R. Jakesz, W. Jonat, Michael Gnant, Martina Mittlboeck, Richard Greil, Christoph Tausch, Joern Hilfrich, W. Kwasny, Christian Menzel, Hellmut Samonigg, Michael Seifert, G. Gademann, Manfred Kaufmann - The Lancet 2005 cited by 876

  6. Neoadjuvant Treatment With Trastuzumab in HER2-Positive Breast Cancer: Results From the GeparQuattro Study

    Authors: Michael Untch, Mahdi Rezai, Sibylle Loibl, Peter A. Fasching, Jens Huober, Hans Tesch, Ingo Bauerfeind, J. Hilfrich, Holger Eidtmann, Bernd Gerber, Claus Hanusch, Thorsten Kühn, Andreas du Bois, Jens‐Uwe Blohmer, Christoph Thomssen, Serban Dan Costa, Christian Jackisch, Manfred Kaufmann, Keyur Mehta, Gϋnter von Minckwitz - Journal of Clinical Oncology 2010 cited by 557

  7. T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers

    Authors: Achim Rody, Uwe Holtrich, L. Pusztai, Cornelia Liedtke, R. Gaetje, Eugen Ruckhaeberle, Christine Solbach, Lars Hanker, A. Ahr, Dirk Metzler, Knut Engels, Thomas Karn, Manfred Kaufmann - Breast Cancer Research 2009 cited by 482

  8. 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial

    Authors: Ian Smith, Marion Procter, Richard D. Gelber, Sébastien Guillaume, A. Feyereislova, Mitch Dowsett, Aron Goldhirsch, Michael Untch, Gabriella Mariani, José Baselga, Manfred Kaufmann, David Cameron, Richard H. Bell, Jonas Bergh, Robert L. Coleman, Andrew Wardley, Nadia Harbeck, R.I. Lopez, Peter Mallmann, Karen A. Gelmon, Nicholas Wilcken, Erik Wist, Pedro Sánchez‐Rovira, Martine Piccart - The Lancet 2007 cited by 1,511

  9. From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression

    Authors: Oleg Schmidt‐Kittler, Thomas Ragg, Angela Daskalakis, Martin Granzow, A. Ahr, Thomas Blankenstein, Manfred Kaufmann, Joachim Diebold, H Arnholdt, Peter E. Müller, Joachim Bischoff, Detlev Harich, Günter Schlimok, Gert Riethmüller, Roland Eils, Christoph A. Klein - National Academy of Sciences, Proceedings of the National Academy of Sciences 2003 cited by 624

  10. Disseminated tumor cells in the bone marrow of patients with ductal carcinoma in situ

    Authors: Nicole Sänger, Katharina E. Effenberger, Sabine Riethdorf, V van Haasteren, J. F. H. Gauwerky, Inka Wiegratz, Klaus Strebhardt, Manfred Kaufmann, Klaus Pantel - International Journal of Cancer 2011 cited by 154

  11. Silencing of the HER2/neu Gene by siRNA Inhibits Proliferation and Induces Apoptosis in HER2/neu-Overexpressing Breast Cancer Cells

    Authors: Timo Faltus, Juping Yuan, Brigitte Zimmer, Andrea Krämer, Sibylle Loibl, Manfred Kaufmann, Klaus Strebhardt - Neoplasia 2004 cited by 142

  12. Reduction in New Metastases in Breast Cancer with Adjuvant Clodronate Treatment

    Authors: Ingo Diel, Erich‐Franz Solomayer, Serban Dan Costa, Christina Gollan, R. Goerner, D. Wallwiener, Manfred Kaufmann, G. Bastert - New England Journal of Medicine 1998 cited by 812

  13. Recommendations From an International Expert Panel on the Use of Neoadjuvant (Primary) Systemic Treatment of Operable Breast Cancer: An Update

    Authors: Manfred Kaufmann, Gabriel N. Hortobágyi, Aron Goldhirsch, Suzy Scholl, Andreas Makris, Pinuccia Valagussa, Jens‐Uwe Blohmer, W. Eiermann, Raimund Jackesz, W. Jonat, Annette Lebeau, Sibylle Loibl, William R. Miller, Sigfried Seeber, Semiglazov Vf, Roy E. Smith, Rainer Souchon, Vered Stearns, Michael Untch, Gϋnter von Minckwitz - Journal of Clinical Oncology 2006 cited by 721

  14. A clinically relevant gene signature in triple negative and basal-like breast cancer

    Authors: Achim Rody, Thomas Karn, Cornelia Liedtke, Lajos Pusztai, Eugen Ruckhaeberle, Lars Hanker, R. Gaetje, Christine Solbach, A. Ahr, Dirk Metzler, Marcus Schmidt, Volkmar Müller, Uwe Holtrich, Manfred Kaufmann - Breast Cancer Research 2011 cited by 336

  15. Recommendations from an International Consensus Conference on the Current Status and Future of Neoadjuvant Systemic Therapy in Primary Breast Cancer

    Authors: Manfred Kaufmann, Gϋnter von Minckwitz, E Mamounas, David Cameron, Lisa A. Carey, Massimo Cristofanilli, Carsten Denkert, W. Eiermann, Michael Gnant, Jay R. Harris, Thomas Karn, Cornelia Liedtke, Davide Mauri, Roman Rouzier, Eugen Ruckhaeberle, Semiglazov Vf, W. Fraser Symmans, Andrew Tutt, Lajos Pusztai - Annals of Surgical Oncology 2011 cited by 498

  16. Lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-taxane-based chemotherapy (GeparQuinto, GBG 44): a randomised phase 3 trial

    Authors: Michael Untch, Sibylle Loibl, Joachim Bischoff, Holger Eidtmann, Manfred Kaufmann, Jens‐Uwe Blohmer, J. Hilfrich, Dirk Strumberg, Peter A. Fasching, R. Kreienberg, Hans Tesch, Claus Hanusch, Bernd Gerber, Mahdi Rezai, Christian Jackisch, Jens Huober, Thorsten Kühn, Valentina Nekljudova, Gϋnter von Minckwitz - The Lancet Oncology 2012 cited by 454

  17. Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer

    Authors: Eugen Ruckhäberle, Achim Rody, Knut Engels, R. Gaetje, Gϋnter von Minckwitz, Susanne Schiffmann, Sabine Grösch, Gerd Geißlinger, Uwe Holtrich, Thomas Karn, Manfred Kaufmann - Breast Cancer Research and Treatment 2007 cited by 297

  18. Treatment of breast cancer during pregnancy: an observational study

    Authors: Sibylle Loibl, Sileny Han, Gϋnter von Minckwitz, M. Bontenbal, Alistair Ring, Jerzy Giermek, Tanja Fehm, Kristel Van Calsteren, Sabine C. Linn, B. Schlehe, Mina Mhallem Gzirí, Pieter J. Westenend, Volkmar Müller, Liesbeth Heyns, Brigitte Rack, Ben Van Calster, Nadia Harbeck, Miriam Lenhard, M Halaška, Manfred Kaufmann, Valentina Nekljudova, Frédéric Amant - The Lancet Oncology 2012 cited by 294

  19. Capecitabine in Addition to Anthracycline- and Taxane-Based Neoadjuvant Treatment in Patients With Primary Breast Cancer: Phase III GeparQuattro Study

    Authors: Gϋnter von Minckwitz, Mahdi Rezai, Sibylle Loibl, Peter A. Fasching, Jens Huober, Hans Tesch, Ingo Bauerfeind, J. Hilfrich, Holger Eidtmann, Bernd Gerber, Claus Hanusch, Thorsten Kühn, Andreas du Bois, Jens‐Uwe Blohmer, Christoph Thomssen, Serban Dan Costa, Christian Jackisch, Manfred Kaufmann, Keyur Mehta, Michael Untch - Journal of Clinical Oncology 2010 cited by 230

  20. Cyclin B1 depletion inhibits proliferation and induces apoptosis in human tumor cells

    Authors: Juping Yuan, Ruilan Yan, Andrea Krämer, Frank Eckerdt, Marc Roller, Manfred Kaufmann, Klaus Strebhardt - Oncogene 2004 cited by 201

  21. Impact of treatment characteristics on response of different breast cancer phenotypes: pooled analysis of the German neo-adjuvant chemotherapy trials

    Authors: Gϋnter von Minckwitz, Michael Untch, Eveline Nüesch, Sibylle Loibl, Manfred Kaufmann, Sherko Kümmel, Peter A. Fasching, W. Eiermann, Jens‐Uwe Blohmer, Serban Dan Costa, Keyur Mehta, J. Hilfrich, Christian Jackisch, Bernd Gerber, Andreas du Bois, Jens Huober, Claus Hanusch, Gottfried E. Konecny, W. Fett, Elmar Stickeler, Nadia Harbeck, Volkmar Müller, Peter Jüni - Breast Cancer Research and Treatment 2010 cited by 277

  22. Randomized Phase III Trial of Pegylated Liposomal Doxorubicin Versus Vinorelbine or Mitomycin C Plus Vinblastine in Women With Taxane-Refractory Advanced Breast Cancer

    Authors: Alan Keller, Robert Mennel, Vassilis A. Georgoulias, Jean‐Marc Nabholtz, Aura Erazo, Aňa Lluch, Charles L. Vogel, Manfred Kaufmann, Gunther von Minckwitz, I. Craig Henderson, L. Mellars, Leila Alland, Craig Tendler - Journal of Clinical Oncology 2004 cited by 212

  23. Targeting cyclin B1 inhibits proliferation and sensitizes breast cancer cells to taxol

    Authors: I Androic, Andrea Krämer, Ruilan Yan, Franz Rödel, R. Gätje, Manfred Kaufmann, Klaus Strebhardt, Juping Yuan - BMC Cancer 2008 cited by 115

  24. Trastuzumab Beyond Progression in Human Epidermal Growth Factor Receptor 2–Positive Advanced Breast Cancer: A German Breast Group 26/Breast International Group 03-05 Study

    Authors: Gϋnter von Minckwitz, Andreas du Bois, Marcus Schmidt, Nicolaì Maass, Tanja Čufer, Felix E. de Jongh, E. Maartense, Christoph Zielinski, Manfred Kaufmann, Wolfgang Bauer, Klaus Baumann, Michael Clemens, Ralph Duerr, Christoph Uleer, Michael Andersson, Robert C. Stein, Valentina Nekljudova, Sibylle Loibl - Journal of Clinical Oncology 2009 cited by 689